Haemophilus parainfluenzae – Bacterium, Infections and Treatment
Haemophilus parainfluenzae is a gram-negative bacterium that is part of the normal oral flora but can cause serious infections such as endocarditis or respiratory disease.
Wissenswertes über "Haemophilus parainfluenzae"
Haemophilus parainfluenzae is a gram-negative bacterium that is part of the normal oral flora but can cause serious infections such as endocarditis or respiratory disease.
What is Haemophilus parainfluenzae?
Haemophilus parainfluenzae is a gram-negative, facultatively anaerobic rod-shaped bacterium belonging to the family Pasteurellaceae. It is a natural commensal of the human oropharynx and upper respiratory tract. Although it is typically harmless in healthy individuals, it can cause serious infections under certain conditions – particularly in immunocompromised patients or those with pre-existing heart disease.
Occurrence and Transmission
The bacterium colonizes the mucosal surfaces of the oropharynx in a large proportion of the healthy population. Transmission occurs primarily through:
- Droplet infection (e.g., coughing, sneezing)
- Direct contact with infected mucous membranes
- Endogenous spread from the individual's own flora when host defenses are impaired
Diseases Caused by Haemophilus parainfluenzae
In most cases, colonization is asymptomatic. However, in certain risk groups, the bacterium can act as a pathogen and cause the following conditions:
- Infective endocarditis: One of the most frequent and severe manifestations, especially in patients with pre-damaged heart valves. H. parainfluenzae belongs to the so-called HACEK group (Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella), known for causing slow-growing endocarditis.
- Respiratory tract infections: Bronchitis, pneumonia, and exacerbations of chronic obstructive pulmonary disease (COPD)
- Sinusitis: Inflammation of the paranasal sinuses
- Otitis media: Middle ear infection, especially in children
- Meningitis: Inflammation of the meninges (rare, mainly in immunocompromised individuals)
- Septic arthritis: Joint infection
- Urinary tract infections: Rare, primarily in immunosuppressed patients
Symptoms
Symptoms depend largely on the site of infection:
- Endocarditis: Fever, night sweats, fatigue, heart murmur, weight loss
- Respiratory infections: Cough, sputum production, shortness of breath, fever
- Sinusitis: Facial pain, nasal congestion, headache
- Otitis media: Ear pain, hearing loss, fever in children
Diagnosis
Diagnosis of Haemophilus parainfluenzae infection is established through microbiological investigations:
- Blood culture: The gold standard when endocarditis or bacteremia is suspected; the organism grows slowly and often requires prolonged incubation times
- Swab and culture: From throat secretions, sputum, sinus aspirate, or middle ear fluid
- PCR (polymerase chain reaction): Molecular testing for rapid identification
- Echocardiography: When endocarditis is suspected, to detect vegetations on heart valves
- Antibiogram: To determine antibiotic susceptibility, as resistance – particularly to ampicillin via beta-lactamase production – is possible
Treatment
Therapy depends on the site of infection and the resistance profile of the pathogen:
Antibiotic Therapy
- Amoxicillin-clavulanate: Drug of choice for beta-lactamase-producing strains
- Third-generation cephalosporins (e.g., ceftriaxone): Commonly used for severe infections such as endocarditis or meningitis
- Fluoroquinolones (e.g., ciprofloxacin, levofloxacin): Alternative for patients with beta-lactam intolerance
- Ampicillin: Used when susceptibility is confirmed (non-beta-lactamase-producing strains)
Duration of Treatment
For endocarditis, treatment typically lasts four to six weeks with intravenous antibiotics. For uncomplicated respiratory tract infections, a shorter course of seven to fourteen days is standard.
Surgical Intervention
In cases of severe endocarditis with significant heart valve damage or treatment-refractory infection, surgical intervention (valve replacement) may be necessary.
Risk Factors
Certain groups are at increased risk for invasive infections caused by H. parainfluenzae:
- Patients with pre-existing heart valve disease
- Immunocompromised individuals (e.g., HIV patients, chemotherapy patients)
- Elderly individuals
- Patients with COPD or other chronic lung diseases
- Premature infants and neonates
Distinction from Haemophilus influenzae
Haemophilus parainfluenzae is frequently confused with Haemophilus influenzae. A key microbiological difference lies in growth factor requirements: while H. influenzae requires both factor X (hemin) and factor V (NAD), H. parainfluenzae only requires factor V. An effective vaccine exists against H. influenzae type b (the Hib vaccine), but no vaccine is currently available for H. parainfluenzae.
References
- Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 9th Edition, Elsevier (2020)
- European Society of Cardiology (ESC) – Guidelines on Infective Endocarditis (2023). Available at: https://www.escardio.org
- Petti CA et al. – HACEK Endocarditis: Characteristics and Outcomes. PubMed, Journal of Clinical Microbiology (2018). Available at: https://pubmed.ncbi.nlm.nih.gov
Best-selling products
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryPrice-Jones Curve
Picornaviridae
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Haemophilus parainfluenzae + Haemophilus para-influenzae + H. parainfluenzae